News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Andy Keller, PhD

Articles by Andy Keller, PhD

Building a Resilient Future: Addressing Youth Mental Health

ByErin Smith,Debbie Beck, EdD,Andy Keller, PhD,William Hynes, DPhil,Harris A. Eyre, MD, PhD

April 25th 2022

We must prioritize youth mental health for a flourishing and resilient American future.

Using this new model to link brain-based innovation with economics.

Brain Capital Foundry: Accelerating Responsible Innovation

ByErin Smith,Walter D. Dawson, DPhil,James T. Hackett,Stephen T. Wong, PhD,Francois Véron,Michael Berk, MD, PhD,William Hynes, DPhil,Andy Keller, PhD,Ernestine Fu, PhD,Shuo Chen, JD,Harris A. Eyre, MD, PhD

January 22nd 2022

How can this new model help us link brain-based innovation with economics?

Latest Updated Articles

Building a Resilient Future: Addressing Youth Mental Health
April 25th 2022

Trending on Psychiatric Times

Monoamines: A Full House

Dose Lithium Once a Day at Night: An Update

Addressing Sexual Wellness: A Psychiatric Perspective

Artificial Intelligence in Psychopharmacology: Promise and Pitfalls, With Roy Perlis, MD

Consensus on Overcoming Barriers to Long-Acting Injectable Use in Schizophrenia